Inverse association between age and inflammatory disease activity in multiple sclerosis

Benjamin M Segal^{1

2}

Affiliations

¹ Department of Neurology, The Ohio State University, Columbus, OH, USA. benjamin.segal@osumc.edu.
² Neuroscience Research Institute, The Ohio State University, Columbus, OH, USA. benjamin.segal@osumc.edu.

Comment

Benjamin M Segal. Nat Rev Neurol. 2023 Oct.

. 2023 Oct;19(10):577-578.

doi: 10.1038/s41582-023-00844-9.

Benjamin M Segal^{1

2}

¹ Department of Neurology, The Ohio State University, Columbus, OH, USA. benjamin.segal@osumc.edu.
² Neuroscience Research Institute, The Ohio State University, Columbus, OH, USA. benjamin.segal@osumc.edu.

No abstract available

Comment on

Association between age and inflammatory disease activity on magnetic resonance imaging in relapse onset multiple sclerosis during long-term follow-up.
Coerver E, Janssens S, Ahmed A, Wessels M, van Kempen Z, Jasperse B, Barkhof F, Koch M, Mostert J, Uitdehaag B, Killestein J, Strijbis E. Coerver E, et al. Eur J Neurol. 2023 Aug;30(8):2385-2392. doi: 10.1111/ene.15862. Epub 2023 May 26. Eur J Neurol. 2023. PMID: 37170817
Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis.
Strijbis EM, Coerver E, Mostert J, van Kempen ZLE, Killestein J, Comtois J, Repovic P, Bowen JD, Cutter G, Koch M. Strijbis EM, et al. J Neurol Neurosurg Psychiatry. 2023 Oct;94(10):792-799. doi: 10.1136/jnnp-2022-330887. Epub 2023 May 12. J Neurol Neurosurg Psychiatry. 2023. PMID: 37173129

1. Rae-Grant, A. et al. Comprehensive systematic review summary: disease-modifying therapies for adults with multiple sclerosis: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 90, 789–800 (2018). - DOI - PubMed
1. Weideman, A. M., Tapia-Maltos, M. A., Johnson, K., Greenwood, M. & Bielekova, B. Meta-analysis of the age-dependent efficacy of multiple sclerosis treatments. Front. Neurol. 8, 577 (2017). - DOI - PubMed - PMC
1. Segal, B. M. CNS chemokines, cytokines, and dendritic cells in autoimmune demyelination. J. Neurol. Sci. 228, 210–214 (2005). - DOI - PubMed
1. Tortorella, C. et al. Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis. J. Neurol. Sci. 239, 95–99 (2005). - DOI - PubMed
1. Tremlett, H., Zhao, Y., Joseph, J. & Devonshire, V., the UBCMS Clinic Neurologists. Relapses in multiple sclerosis are age- and time-dependent. J. Neurol. Neurosurg. Psychiatry 79, 1368–1374 (2008). - DOI - PubMed